Rimon\u2019s team of Life Sciences attorneys have extensive experience working with clients in the biotechnology, pharmaceutical, medical device, vape- and wellness-product industries. We have represented Life Sciences clients ranging from start-up companies to multinational publicly traded clients in connection with both their corporate and litigation matters. In terms of corporate representation, Rimon counsels and defends Life Sciences clients in securities offerings (including angel investments, venture financings, private placements, and public offerings), mergers and acquisitions, employment and compensation law, licensing, intellectual property litigation, patent procurement and counseling, and numerous complex corporate transactions.\u00a0 Our attorneys provide healthcare providers and business associates of all sizes, ranging from small scale to those with nationwide operations, with advice on Health Insurance Portability and Accountability Act (“HIPAA”) compliance. We have also represented both licensees and licensors in technology transfers from universities and research institutions to operating companies.<\/p>\n
We also counsel and defend Life Sciences clients involved in litigation, including pharmaceutical and medical device products liability cases filed in state and federal courts involving claims of defective manufacture and design, and the failure to warn. We have tried these cases to verdict and secured dismissals or summary judgments and have also resolved them in mediations and arbitrations. We have also served as counsel for our Life Sciences clients in both coordinated state proceedings and in federal multi-district litigation. Our attorneys have represented major international manufacturers of tobacco, vape, and related products in connection with the successful defense of litigation in the UK, Ireland, continental Europe, India, and the Middle East, and have advised manufacturers in the tobacco, vape, and wellness industries with regard to mitigating litigation risk and addressing product stewardship issues. We understand the importance of federal law and the applicable FDA regulations regarding drugs and devices, as well as tobacco, vape, and wellness products, and deploy that knowledge in defense of our clients.<\/p>\n
Our team\u2019s success is built upon a true \u201cclient-first\u201d approach, which focuses on working closely with our clients to understand their needs and recognize opportunities in a constantly changing legal and commercial landscape. We also understand that the needs of our Life Sciences clients are multi-faceted. To offer comprehensive service, our Life Sciences partners collaborate closely with attorneys across the firm to assist our clients, make connections with management and board members, arrange angel and venture capital financing, access capital markets, engage with corporate and university partners, advise on mergers and acquisitions, and protect and monetize their IP. And when our Life Sciences clients are involved in litigation, we take time at the outset to learn their businesses and understand their products to craft the best defense.<\/p>\n